Autoimmune diseases usually arise as a result of an aberrant immune system attack on
normal tissues of the body, which leads to a cascade of inflammatory reactions. The immune …

The lipid-based colloidal carriers, such as nanostructured lipid carriers (NLCs), solid lipid
nanoparticles (SLNs), nanocapsules, liposomes, and microemulsion, are the latest and …

The nasal route has been investigated as a promising alternative for drug delivery to the
central nervous system, avoiding passage through the blood–brain barrier and improving …

The intra-articular administration of conventional drug solutions or dispersions in joint
diseases such as osteoarthritis has a relatively short retention time and, therefore, limited …

Imatinib (IMT) is a tyrosine kinase enzyme inhibitor and extensively used for the treatment of
gastrointestinal stromal tumors (GISTs). A nanostructured lipid carrier system (NLCS) …

Rheumatoid arthritis (RA) is a chronic inflammatory autoimmune disease characterized by
an inflammatory microenvironment and cartilage erosion within the joint cavity. Currently …

Rheumatoid arthritis is among the most common disabling diseases associated with chronic
inflammation. The efficacy of the current therapeutic strategies is limited; therefore, new …

Rheumatoid Arthritis (RA) yet remains the most widely faced autoimmune disorder
worldwide. Progression of RA has been linked with debilitating effects on various organ …

Background: In the past two decades, extensive research has focused on lipid nanocarriers
for targeted drug delivery to treat various diseases. Among these, inflammatory conditions …

Background: In the past two decades, extensive research has focused on lipid nanocarriers
for targeted drug delivery to treat various diseases. Among these, inflammatory conditions …